Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACOPP-21 in Elderly Patients with Hodgkin's Lymphoma
NCT00284271Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jan 2004
- Primary completion
- Dec 2005
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Started Jan 2004; status: completed.
02
Drugs
bleomycindoxorubicincyclophosphamidevincristineprocarbazine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00284271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284271.